When should a controlled substance inventory be conducted?

A controlled substance inventory is a critical requirement for pharmacies and prescribers who handle controlled substances. The correct answer states that an inventory should be conducted at initial registration and then every two years thereafter.

This process is essential for maintaining compliance with the Drug Enforcement Administration (DEA) regulations, which mandate that all registrants maintain an accurate inventory of controlled substances to ensure accountability and proper management of these potent medications. Conducting an inventory at initial registration establishes a baseline for the quantities of controlled substances on hand. The follow-up inventory every two years helps to verify that no discrepancies or losses have occurred over time, thus ensuring that all controlled substances are accounted for.

In contrast, conducting an inventory only at initial registration would fail to provide ongoing assurances regarding the control and monitoring of these substances. Monthly inventories could create an unnecessary burden and might not be feasible for many facilities. Annual inventories may not align with the regulatory requirement of every two years, making it insufficient in terms of compliance with the law. Overall, the timing of inventory checks is designed to align with both regulatory compliance and effective management of controlled substances.